IONIS PHARMACEUTICALS INC
IONS
63 insider filings · Latest: Jun 26, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | Jan 31 1:40 AM | BENNETT C FRANK | Proposed Sale | 5,885 | $82.91 | $487.9K | — | View → |
| Jan 30, 2026 | Jan 31 1:34 AM | HOUGEN ELIZABETH L | Proposed Sale | 6,988 | $83.01 | $580.0K | — | View → |
| Jan 30, 2026 | Jan 31 1:23 AM | Monia Brett P | Proposed Sale | 62,970 | $82.96 | $5.2M | — | View → |
| Jan 30, 2026 | Jan 31 1:20 AM | O'NEIL PATRICK R. | Proposed Sale | 6,179 | $83.01 | $512.9K | — | View → |
| Jan 30, 2026 | Jan 31 1:19 AM | Swayze Eric | Proposed Sale | 6,179 | $83.01 | $512.9K | — | View → |
| Jan 30, 2026 | Jan 31 1:14 AM | Schneider Eugene | Proposed Sale | 6,179 | $83.01 | $512.9K | — | View → |
| Jan 22, 2026 | Jan 23 10:51 PM | Shannon L. DeversEVP, Chief Human Resources Ofc | Sale | 3,977 | $81.34 | $323.5K | 22,541(D) | View → |
| Jan 22, 2026 | Jan 23 9:05 PM | Devers Shannon L. | Proposed Sale | 3,977 | $81.34 | $323.5K | — | View → |
| Jan 22, 2026 | Jan 22 9:07 PM | Devers Shannon L. | Proposed Sale | 3,977 | $81.34 | $323.5K | — | View → |
| Jan 16, 2026 | Jan 21 4:51 PM | Baroldi Mariana | Proposed Sale | 1,171 | $80.00 | $93.7K | — | View → |
| Jan 16, 2026 | Jan 21 1:21 AM | Eric SwayzeEVP Research | Sale | 9,933 | $75.34 | $748.4K | 318(I) | View → |
| Jan 16, 2026 | Jan 21 1:21 AM | Eugene SchneiderEVP, Chf Clinical Develop Ofcr | Sale | 9,302 | $75.59 | $703.1K | 63,890(D) | View → |
| Jan 16, 2026 | Jan 21 1:20 AM | Patrick R. O'NeilEVP CLO & General Counsel | Sale | 9,191 | $75.84 | $697.0K | 66,171(D) | View → |
| Jan 16, 2026 | Jan 21 1:20 AM | Brett P MoniaDirector, Chief Executive Officer | Sale | 44,034 | $74.82 | $3.3M | 224,683(D) | View → |
| Jan 16, 2026 | Jan 21 1:18 AM | Holly B. KordasiewiczEVP, Chief Development Officer | Sale | 4,141 | $75.66 | $313.3K | 14,718(D) | View → |
| Jan 16, 2026 | Jan 21 1:18 AM | Kyle JenneEVP, Chf GL Pdt Str Ofcr | Sale | 1,823 | $75.96 | $138.5K | 16,389(D) | View → |
| Jan 16, 2026 | Jan 21 1:18 AM | HOUGEN ELIZABETH LEVP, Finance & CFO | Sale | 12,922 | $75.22 | $972.0K | 126,307(D) | View → |
| Jan 16, 2026 | Jan 21 1:18 AM | Shannon L. DeversEVP, Chief Human Resources Ofc | Sale | 8,353 | $75.95 | $634.4K | 26,518(D) | View → |
| Jan 16, 2026 | Jan 21 1:18 AM | Brian BirchlerEVP, Corp and Development Ops | Sale | 8,480 | $75.11 | $636.9K | 60,435(D) | View → |
| Jan 16, 2026 | Jan 21 1:18 AM | BENNETT C FRANKEVP, Chief Scientific Officer | Sale | 8,977 | $75.15 | $674.6K | 94,757(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | Mar 11 8:19 PM | Brett P MoniaDirector, Chief Executive Officer | Option Exercise | 114,351 | $60.89 | 34,103(D) | View → |
| Mar 10, 2026 | Mar 11 8:18 PM | Kyle JenneEVP, Chf GL Pdt Str Ofcr | Option Exercise | 37,277 | $46.10 | 32,601(D) | View → |
| Mar 4, 2026 | Mar 5 11:14 PM | Joseph LoscalzoDirector | Option Exercise | 200 | $38.06 | 10,968(D) | View → |
| Mar 3, 2026 | Mar 5 11:14 PM | Joseph LoscalzoDirector | Option Exercise | 832 | $38.06 | 11,168(D) | View → |
| Mar 3, 2026 | Mar 5 11:14 PM | Joseph Klein IIIDirector | Option Exercise | 16,000 | $42.88 | 0(D) | View → |
| Mar 3, 2026 | Mar 5 11:14 PM | Allene M. DiazDirector | Option Exercise | 40,321 | $41.08 | 0(D) | View → |
| Mar 3, 2026 | Mar 5 11:14 PM | Shannon L. DeversEVP, Chief Human Resources Ofc | Option Exercise | 20,106 | $52.87 | 8,877(D) | View → |
| Mar 3, 2026 | Mar 5 11:13 PM | BENNETT C FRANKEVP, Chief Scientific Officer | Option Exercise | 65,089 | $60.89 | 0(D) | View → |
| Mar 4, 2026 | Mar 5 11:13 PM | Joseph BaroldiEVP, Chief Business Officer | Option Exercise | 439 | $56.78 | 3,866(I) | View → |
| Mar 3, 2026 | Mar 5 11:13 PM | Joseph BaroldiEVP, Chief Business Officer | Option Exercise | 1,699 | $56.78 | 4,104(I) | View → |
| Feb 2, 2026 | Feb 4 9:06 PM | BENNETT C FRANKEVP, Chief Scientific Officer | Option Exercise | 65,089 | $60.89 | 0(D) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Michael J. YangDirector | Option Exercise | 1,930 | — | 7,150(D) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eric SwayzeEVP Research | Grant/Award | 35,700 | $0.00 | 611(I) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eric SwayzeEVP Research | Option Exercise | 21,477 | — | 386(I) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eugene SchneiderEVP, Chf Clinical Develop Ofcr | Option Exercise | 21,685 | — | 39,251(D) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eugene SchneiderEVP, Chf Clinical Develop Ofcr | Grant/Award | 35,475 | $0.00 | 48,926(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Patrick R. O'NeilEVP CLO & General Counsel | Option Exercise | 21,473 | — | 39,251(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Patrick R. O'NeilEVP CLO & General Counsel | Grant/Award | 35,475 | $0.00 | 48,926(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Brett P MoniaDirector, Chief Executive Officer | Grant/Award | 156,585 | $0.00 | 205,719(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Brett P MoniaDirector, Chief Executive Officer | Option Exercise | 89,145 | — | 163,014(D) | View → |